Effects of slowed gastrointestinal motility on levodopa pharmacokinetics

Autonomic Neuroscience: Basic and Clinical

Volumn 156, Issue 1-2, 2010, Pages 67-72

  Fernández, Nélida ^a   García, Juan J ^a   Diez, M José ^a   Sahagún, Ana M ^a   González, Aranzazu ^a   Díez, Raquel ^a   Sierra, Matilde ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

Biperiden; Levodopa; Pharmacokinetics; Rabbits; Slowed gastrointestinal motility

Indexed keywords

BIPERIDEN; CARBIDOPA PLUS LEVODOPA; LEVODOPA;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ISOLATION; DRUG STABILITY; GASTROINTESTINAL MOTILITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RABBIT; STOMACH EMPTYING;

ANIMALS; GASTROINTESTINAL MOTILITY; INTESTINAL ABSORPTION; LEVODOPA; PARKINSON DISEASE; RABBITS;

EID: 77955277018     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2010.03.016     Document Type: Article

References (20)

1. Bredberg E., Tedroff J., Aquilonius S.M., Paalzow L. Pharmacokinetics and effects of levodopa in advanced Parkinson's disease. Eur. J. Clin. Pharmacol. 1990, 39:385-389.
2. Contin M., Riva R., Albani F., Baruzzi A. Pharmacokinetic optimisation in the treatment of Parkinson's disease. Clin. Pharmacokinet. 1996, 30:463-481.
3. Cummings J., Matheson L.M., Smyth J.F. Method for the determination of gamma-L-glutamyl-L-dihydroxyphenylalanine and its major metabolites L-dihydroxyphenylalanine, dopamine and 3,4-dihydroxyphenylacetic acid by highperformance liquid chromatography with electrochemical detection. J. Chromatogr. 1990, 528:43-53.
4. Djaldetti R., Baron J., Ziv I., Melamed E. Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Neurology 1996, 46:1051-1054.
5. Edwards L.L., Quigley E.M., Pfeiffer R.E. Gastrointestinal symptoms in Parkinson's disease: 18month follow-up study. Mov. Disord. 1993, 8:83-87.
6. Fernandez N., Carriedo D., Sierra M., Diez M.J., Sahagun A., Calle A., Gonzalez A., Garcia J.J. Hydrosoluble fiber (Plantago ovata husk) and levodopa II: experimental study of the pharmacokinetic interaction in the presence of carbidopa. Eur. Neuropsychopharmacol. 2005, 15:505-509.
7. Fernandez N., Prieto C., Sierra M., Diez M.J., Sahagun A., Gonzalez A., Garcia J.J. Evolution of the bioavailability and other pharmacokinetic parameters of levodopa (with carbidopa) in rabbits. Meth. Find. Exp. Pharmacol. 2008, 30:1-7.
8. Garcia J.J., Fernandez N., Carriedo D., Diez M.J., Sahagun A., Gonzalez A., Calle A., Sierra M. Hydrosoluble fiber (Plantago ovata husk) and levodopa I: experimental study of the pharmacokinetic interaction. Eur. Neuropsychopharmacol. 2005, 15:497-503.
9. Gibaldi M., Perrier D. Multicompartment models. Pharmacokinetics 1982, Marcel Dekker, New York. 2nd ed.
10. Hardoff R., Saula M., Tamir A., Soil A., Front A., Badarna S., Honigman S., Giladi N. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov. Disord. 2001, 16:1041-1047.
11. Kempster P.A., Frankel J.P., Bovingdon M., Webster R., Lees A.J., Stern G.M. Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease. J. Neurol. Neurosurg. Psychiatr. 1989, 52:718-723.
12. Korczyn A.D. Autonomic nervous system screening in patients with early Parkinson's disease. Early Diagnosis and Preventive Therapy in Parkinson's Disease 1989, 41-48. Springer-Verlag, Vienna. H. Przuntek, P. Riederer (Eds.).
13. Kurlan R., Rothfield K.P., Woodward W.R., Nutt J.G., Miller C., Lichter D., Shoulson I. Erratic gastric emptying of levodopa may cause random fluctuations of parkinsonian mobility. Neurology 1988, 38:419-421.
14. Mouradian M.M., Heuser I.J., Baronti F., Chase T.N. Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease. Ann. Neurol. 1990, 27:18-23.
15. Nutt J.G. On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics. Ann. Neurol. 1987, 22:535-540.
16. Nutt J.G., Fellman J.H. Pharmacokinetics of levodopa. Clin. Neuropharmacol. 1984, 7:35-49.
17. Nyholm D., Asmark H., Gomes-Trolin C. Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets. Clin. Neuropharmacol. 2003, 26:156-163.
18. Pfeiffer R.F. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol. 2003, 2:107-115.
19. Shoulson I., Glaubiger G.A., Chase T.N. On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients. Neurology 1975, 25:1144-1148.
20. Wilk J.B., Lash T.L. Risk factor studies of age-at-onset in a sample ascertained for Parkinson disease affected sibling pairs: a cautionary tale. Them. Epidemiol. 2007, 4:1-6.